SCHEMBL7141114

SCHEMBL7141114

CCc1ccc(C2(C(N)=O)CCCCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.55
SMN1; SMN2 Q16637 5/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TSHR P16473 1/20 0.43
HDAC4 P56524 4/20 0.42
RAB9A P51151 1/20 0.41
AKR1C1 Q04828 1/20 0.41
NPSR1 Q6W5P4 3/20 0.40
GAA P10253 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HSD11B1 P28845 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ERCC1 P07992 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30207658 0.86 LMNA (0.54) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL19817375 0.82 LMNA (0.50) LMNASMN1; SMN2ALDH1A1MAPTMEN1
SCHEMBL8298271 0.81 LMNA (0.54) LMNASMN1; SMN2MEN1KMT2ATSHR
SCHEMBL4992446 0.81 LMNA (0.59) LMNASMN1; SMN2ALDH1A1MAPTMEN1
SCHEMBL4558509 0.81 HDAC4 (0.51) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL5510283 0.80 KMT2A (0.57) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL18291767 0.79 OPRL1 (0.55) LMNAALDH1A1MAPTKMT2ATSHR
SCHEMBL16789667 0.79 OPRL1 (0.55) LMNAALDH1A1MAPT
SCHEMBL22027131 0.79 LMNA (0.57) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL6202789 0.79 LMNA (0.57) LMNASMN1; SMN2ALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074511-A Substituted benzodiazoles and their use in therapy 托马斯·黑勒戴药物研究基金会 2020-12-11 CN disclosed
EP-1286978-A1 CYCLOHEXYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LTD. (GB) 2003-03-05 EP disclosed
WO-2001087866-A1 CYCLOHEXYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 2001-11-22 WO disclosed
EP-0898569-A1 PIPERIDINES AND PYRROLIDINES MERCK PATENT GmbH (DE) 1999-03-03 EP disclosed
WO-1997040038-A1 PIPERIDINES AND PYRROLIDINES MERCK PATENT GMBH (DE) 1997-10-30 WO disclosed